Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Jul;62(7):950–959. doi: 10.1002/acr.20154

Table 2.

Change in Disease Activity Scores with Physician-rated and Parent-rated cSLE Course

Change in Core Set Variables (A) Worsening (n of episodes = 89) (B) No Change (n of episodes = 348) (C) Improvement (n of episodes = 89) (A) vs. (B) (A) vs. (C) (B) vs. (C)

Physician-rated Change in cSLE Course

VASMD 1.23 ± 0.12 −0.18 ± 0.06 −1.01 ± 0.12 < 0.001 < 0.001 < 0.001
ECLAM 0.97 ± 0.16 0.02 ± 0.08 −1.12 ± 0.16 < 0.001 < 0.001 < 0.001
SLEDAI 1.56 ± 0.33 −0.09 ± 0.17 −2.27 ± 0.33 < 0.001 < 0.001 < 0.001
SLAM 1.78 ± 0.76 −0.01 ± 0.38 −1.78 ± 0.78 < 0.1 < 0.01 NS *
BILAGLiang 3.23 ± 0.70 −0.62 ± 0.35 −4.61 ± 0.70 < 0.001 < 0.001 < 0.001
BILAGGladman 1.18 ± 0.23 −0.08 ± 0.12 −1.22 ± 0.23 < 0.001 < 0.001 < 0.001
BILAGStoll 1.85 ± 0.39 −0.35 ± 0.20 −2.79 ± 0.39 < 0.001 < 0.001 < 0.001

Parent-rated Change in Patient Well-being

VASMD 0.42 ± 0.18 −0.03 ± 0.09 −0.24 ± 0.09 < 0.1 < 0.01 NS
ECLAM 0.65 ± 0.22 0.03 ± 0.10 −0.25 ± 0.11 < 0.05 < 0.001 NS
SLEDAI 1.04 ± 0.45 −0.03 ± 0.21 −0.66 ± 0.23 < 0.1 < 0.01 NS
SLAM 1.83 ± 0.98 −0.29 ± 0.46 −0.04 ± 0.50 NS NS NS
BILAGLiang 2.98 ± 0.93 −0.34 ± 0.44 −1.81 ± 0.47 < 0.01 < 0.001 < 0.1
BILAGGladman 1.22 ± 0.30 0.02 ± 0.14 −0.43 ± 0.15 < 0.01 < 0.001 < 0.1
BILAGStoll 1.53 ± 0.53 −0.29 ± 0.25 −0.97 ± 0.27 < 0.01 < 0.001 NS

For additional information please see footnotes of Table 1

Values presented are means and standard errors (SE)

*

NS = Not significant.

P-values are based on mixed models using the Tukey-procedure for post-hoc correction